The study describes construction of five recombinant very virulent (vv) and very virulent plus (vv+) strains lacking meq and viral telomerase (vTR). Deletion of both copies of meq and vTR was achieved by Red E/T recombination in GS1783 E. coli cells. The constructed bacterial artificial chromosome (BAC) clones reconstituted in chicken embryo fibroblasts were examined by immunofluorescence assay to compare the features of recombinant strains with wild-type viruses. The results demonstrated that recombinant BAC strains caused slightly reduced cytophatic effect and decreased level of the fluorescence obtained from the monoclonal antibody in comparison to the parental viruses. Generation of recombinant BAC clones may provide more detailed information on the function of Marek's disease virus oncogenes and the potential use of recombinants for the preparation of the new vaccine against Marek's disease.
Marek's disease virus (MDV) causes Marek's disease (MD) in chickens and is one of the most important economical threats in production of chickens, turkeys, and Japanese quail (11) . Similarly to other members of Herpesviridae family, the virus has a large genome ranging from 178 to 200 kbp. The genome is flanked by terminal and internal repeated sequences of unique long and short regions (TR L -IR L and TR S -IR S ). These junctions encode protein involved in virus replication but also factors of its oncogenicity (1, 13) . A considerable development of genetic engineering techniques including cloning of large herpesvirus genomes as bacterial artificial chromosome (BAC) created the possibility to clone the whole MDV genome using mini-F plasmid-based vector (5, 6, 9) . This has created the way for a detailed molecular analysis of the function of particular virus genes, including MDV oncogenes like meq and viral telomerase (vTR) (1, 16, 20) . Meq as the protein containing N-terminal basic leucine zipper (bZIP) belongs to the family of Jun/Fos oncogenes that mediates dimerisation with the proapoptotic factors and leads to modulation of the function of cellular and viral proteins (3) . Meanwhile, the internal IR L -IR S junction in MDV genome consists of telomeric sequences. This facilitates MDV integration into the telomeres of host cellular DNA. The virus also encodes telomerase enzyme (vTR) that compensates shortening of the cellular telomeres and it is believed to take part in tumour progression and dissemination (7) .
The telomerase consists of two elements: telomerase reverse transcriptase (TERT) and telomerase RNA (TR). The TR is acting as a template for TERT and catalyses addition of telomeres to the end of chromosomes (4, 7) . Previously conducted studies on the construction of BAC were applied for cloning of all three MDV serotypes including both virulent and attenuated strains belonging to the 1 st serotype (14, 16, 19) . The recent studies describe the use of recombinant BAC clones lacking meq oncogenes as potential candidates for the future vaccines (12, 13, 16) . This aspect is especially important taking into account the long history of vaccination against MD (11, 21) . The vaccines applied so far include herpesvirus of turkey (HVT), MDV-2 strain SB-1, as well as the most powerful CVI988 (Rispens) known as the 'golden standard' in vaccination. Cloning of the whole virulent MDV genomes may facilitate the application of mutant viruses as future vaccines. The study describes the generation and the subsequent Red E/T mutagenesis of five very virulent (vv) and very virulent plus (vv+) MDV strains in bacterial artificial chromosomes (BACs). Construction of the infectious BAC clones from the virulent MDV strains might be a better alternative to the currently applied vaccines due to the continuous evolutions of field isolates. Since the clones are antigenically related to recently isolated virulent strains, they may also be proper candidates for future vaccines.
Material and Methods
Viruses. Five virulent MDV strains: 31/07, 23/07, 7/08, 12/09, and 42/09 were used. The strains were isolated from broiler and layer chickens aged from 6 to 27 weeks. The birds aged over 18 weeks showed clinical symptoms including leg paralysis and torticollis. During post-mortem examination, the presence of nodular and focused tumours in the liver and spleen were observed. The 10% (w/v) homogenates in phosphate buffered saline (PBS) from the liver and spleen were used for the isolation of the virulent strains. HPRS 16 reference strain (Houghton Poultry Research Station, Huntingdon, UK) was used as a positive control in the conducted PCRs.
Cell cultures. Primary chicken embryo fibroblasts (CEFs) prepared from 11-day-old SPF chicken embryos (Valo Lohmann, Germany) were used. About 1 x 10 6 seeded CEFs were infected with 100 PFU of each virulent strain used. Three passages of each virus were conducted, then the viruses were stored in a preservative medium containing dimethyl sulfoxide (DMSO) in liquid nitrogen (-196°C) .
DNA extraction. Total DNA was extracted from infected CEFs using a standard phenol-chloroform extraction method followed by 96% ethanol precipitation. The extracted DNA was stored at -80°C until used for further construction of BAC clones.
Construction of the BAC clones. BAC clones were constructed according to previously described procedure (14) . Briefly, the pDS-pHA1 plasmid obtained by the courtesy of Prof. Klaus Osterrieder (Freie Universität Berlin, Germany) containing the mini-F casette flanked by 2.1 and 3.0 kbp homologous regions surrounding the US 2 gene of MDV-1, was applied. The viral DNA from 31/07, 23/07, 7/08, 12/09, and 42/09 strains and pDS-pHA1 vector were used for co-transfection of primary CEFs using calcium phosphate precipitation method or Lipofectamine ® reagent (Invitrogen, USA). The amount of added pDSpHA1 plasmid was 1.5 μg per well while the DNA volume of strains ranged from 2 μL to 4 μL (0.5-2 μg). The transfected cells were passaged five times in selection medium containing mycophenolic acid (200 µg/mL), xanthine (50 µg/mL), and hypoxanthine (100 µg/mL). Next, the DNA of the BACs was extracted using phenol-chlorophorm extraction, then 1.5 µg of extracted DNA was electroporated into E. coli DH10B cells at 1.250 V, a resistance of 200 Ω and 25 μF of capacitance (GenePulser, BioRad, USA). After electroporation, the bacteria were incubated in 0.9 ml of SOC medium at 37°C for 1 h and then plated onto LB agar plates supplemented with chloramphenicol (40 μg/mL). After 24 h of incubation at 37°C, a single colony was picked and used for the inoculation of 2 mL of LB medium with chloramphenicol. Complete BAC clones were extracted by standard alkaline lysis and examined by EcoRI and BamHI digestion (ThermoScientific, USA).
Red E/T mutagenesis. Red E/T recombination was conducted in GS1783 E. coli cells harbouring pYEbac102 plasmid (a kind gift from Dr Gregory Smith, Northwestern University, Chicago, USA). DNA from BACs was electroporated into GS1783 and cultured in LB medium with chloramphenicol (40 μg/mL) at 32°C. The optical density of the cell culture was measured at 600 nm, then, at 0.6 value, the incubation temperature was raised to 42°C for 15 min. Subsequently, 2% arabinose (Sigma-Aldrich, Germany) was added to induce Red E/T system. Afterwards , the bacteria were incubated on ice and prepared for electroporation. PCR product containing kanamycin resistance (aminoglycoside 3'-phosphotransferase) gene and two 50 nt regions flanking meq gene was amplified using the following primers: 5'-atgcggatcatcagggtctcccgtcacctggaaaccaccagaccgtagacA TGAGCCATATTCAACGGGAAACG-3' and 5'-atgtctcaggagccagagccgggcgctatgccctacagtcccgctgacgaT CAGCGTAATGCTCTGCCAGTGT-3' with pDrive vector as a template (Qiagen, Germany). Similarly, to delete both copies of vTR gene, the fragment containing ampicillin resistance gene (β-lactamase) with vTR flanking regions was amplified by primers: 5'-cgcgtgtgggagcgacgccgtccgcgcgccccacggcgcaggggggcgc aTTACCAATGCTTAATCAGT-3', 5'-acacgtggcgggtggaaggctccgctgtgtctaaccctaatcggaggtaAT GAGTATTCAACATTTCCGTG-3'using pDrive Vector (Qiagen, Germany). The obtained PCR products were then introduced into electrocompetent GS1783 cells containing previously prepared BAC clones. The bacteria were incubated at 32°C for 1 h and plated on LB agar plates containing 40 μg/mL of chloramphenicol, 50 μg/mL of kanamycin, and 50 μg/mL of ampicillin to select BAC clones with inserted kanamycin and ampicillin resistance genes into meq and vTR encoding sites. The scheme of constructed deletive BAC clones is presented at Fig. 1 . Recombinant colonies of BACs were examined for the presence of antibiotic resistance genes as well as gB, ICP4, and 132 bp (2) MDV specific genes. The primers sequences are listed in Table 1 . Recombinant BACs were designated as 31/07 meq vTR, 23/07 meq vTR, 7/08 meq vTR, 12/09 meq vTR and 42/09 meq vTR, and then used for the transfection of primary CEFs. After 56 h, the clones were examined with immunofluorescence assay (IFA) on 24-well plates (Nunc, USA). Briefly, the cells were fixed with 90% cold acetone and incubated at -20°C for 20 min. The cells were then washed twice with PBS, incubated for 1 h with primary monoclonal pp38 antibodies (1:200), and then stained with secondary goat anti-mouse IgG conjugated with Alexa 488 dye (1:200) (Serotec) for 1 h. The cell nuclei were stained with 4',6-diamidino-2-phenylindole (DAPI) (0.5µg/mL) for 20 min. The images were analysed by fluorescence microscopy (Axio Observer D1, Zeiss, Germany).
Results
The used field strains of MDV: 31/07, 23/07, 7/08, 12/09, and 42/09 were isolated in primary CEFs. The strains replicated in CEFs and induced the cytophatic effect (CPE), which occurred between 56 and72 h p. i. Seventy two hours after co-transfection of CEFs with DNA of five virulent Polish strains, the presence of the CPE visible as focuses of tiny rounded cells was observed (Fig. 2) . The DNA extracted from E. coli cells was then examined by digestion by EcoRI and BamHI enzymes and separated by gel electrophoresis (Fig. 3) (Fig.4) . The conducted PCRs for the detection of gB, ICP4, and 132 bp genes demonstrated the presence of specific amplicons in five constructed BACs (Fig. 4) . Subsequently, the BAC DNA was transfected into primary CEFs and examined by IFA after 56 h. The obtained cytophatic effect created by mutant viruses displayed minor differences in replication of the viruses since the obtained focuses and plaques were slightly smaller in comparison to the parental strains (Fig. 1) . The observed immunofluorescence confirmed this finding since the fluorescence level given from pp38 monoclonal antibodies that attached to the constructed recombinant BACs was lower (Fig. 5) . Fig. 1 . Construction of recombinant BACs by Red E/T recombination. TR L , TR S -terminal long and short repeats, IR L , IR S -internal long and short repeats, U L , U S -unique long and short sequences, pDS-pHA1 -mini F plasmid for construction of BACs, AmpR amplicillin resistance gene, KanR, -kanamycin resistance gene, 50 nt -fragments with 50 nt homology to the opened reading frames encoding meq and vTR genes, the numbers indicate the homological regions location for 50 nt fragments within MDV genome 
Discussion
The study describes the successful construction of recombinant Marek's disease virus strains originating from five Polish field strains: 31/07, 23/07, 7/08, 12/09, and 42/09. So far, the construction of the recombinant BAC of MDV has been described at least several times (7, 13, 15, 20) . The most frequent modification of MDV BACs included deletive mutants lacking genes involved in MDV horizontal transmission (5, 6) , cancerogenesis (7, 16, 20) , or the function of partial insertions of genes from other poultry viruses (8, 10, 17, 18) . Using BAC technology, Jarosiński et al. (6) conducted the study on the role of three splicing variants of gC protein (UL44) in horizontal transport of MDV. Similarly, they revealed the function of fluorescently tagged vUL49-EGFP tegument protein in context of production of MDV in feather follicle epithelium (FFE) (5). This study was focused on the influence of meq and viral telomerase (vTR) on the MDV replication in vitro by deletion of both copies of these genes. The previously presented studies have shown that deletive BACs lacking the main MDV oncogenes protects chickens against Marek's disease caused by virulent MDV (7, 16, 19 (20) suggested that deletion of both vTR copies slightly impairs the ability to induce lymphomas in MDV infected chickens. They have shown that tumour incidence in chickens infected with the deletive clone of MDV lacking vTR was reduced by 60%. A further study conducted by Kaufer et al. (7) has demonstrated that mutated template for RNA telomerase (TR), which provides the matrix for the chromosomal telomeric repeats eliminates cancerogenesis. The study has shown that recombinant BAC clones lacking meq and vTR oncogenes are still capable to replicate after their reconstitution in CEFs. The integrity of BAC genomes was also confirmed by the conducted PCRs specific for gB, ICP4, and 132 bp genes.
Meanwhile, CPE, as well as the fluorescence level produced by the infected cells were slightly lower in comparison to their parental strains which may indicate the marginal vTR level during MDV infection at early stage. Construction of BACs allows to examine the role of recombinant events between MDV and other viruses of poultry, including reticuloendotheliosis virus (REV) (8, 10, 17, 18) . Recently, Mays et al. (10) have revealed that co-cultivation of the JM/102W MDV strain with REV leads to generation of recombinant MDV strains that contain REV long terminal repeat (LTR). This may cause a decrease in MDV pathogenicity and may alter virus replication. Furthermore, Kim et al. (8) have described that LTR insertion is responsible for the loss of pathogenicity of Md5 strain since the virus was nonpathogenic for chickens after 40 passages in DEFs.
The study has demonstrated that construction of recombinant BAC clones lacking two most important oncogenes does not influence their ability to replicate in CEFs. The minor effect of the mutation was observed on the basis of generated cell focuses and plaques. Further studies on the oncogenicity of the constructed BAC clones will be conducted in chickens to reveal the exact role of the mutations implemented into MDV genome.
